Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03233711||Recruiting||Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer||
||NIH / Other||
||200||All||18 Years and older (Adult, Older Adult)||NCT03233711||NCI-2017-01347
|April 13, 2018||December 30, 2019||December 30, 2019||July 31, 2017||August 20, 2019||